전립선 재생검 방법: 초음파 또는 자기공명영상 유도하에 따른 생검 결과와 수술 후 성적 비교
Purpose: We compared biopsy results and surgical outcomes of magnetic resonance imaging (MRI)-guided biopsy with transrectal ultrasonography (TRUS)-guided biopsy to demonstrate efficacy of MRI-guided biopsy on previous biopsy negative patients. Materials and Methods: We retrospectively reviewed data...
Saved in:
Published in | Journal of Urologic Oncology, 15(2) pp. 72 - 78 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | Korean |
Published |
대한비뇨기종양학회
01.08.2017
|
Subjects | |
Online Access | Get full text |
ISSN | 2951-603X 2982-7043 |
DOI | 10.22465/kjuo.2017.15.2.72 |
Cover
Summary: | Purpose: We compared biopsy results and surgical outcomes of magnetic resonance imaging (MRI)-guided biopsy with transrectal ultrasonography (TRUS)-guided biopsy to demonstrate efficacy of MRI-guided biopsy on previous biopsy negative patients.
Materials and Methods: We retrospectively reviewed data of 120 patients who were categorized into MRI-guided biopsy groups (n=20) and TRUS-guided biopsy groups (n=100). All patients were diagnosed with prostate cancer (PCa) and had undergone radical prostatectomy (RP) after MRI-guided or TRUS-guided repeat biopsy between January 2010 and March 2016. Detection rate of significant cancer and Gleason score upgrading and downgrading were examined, in addition to biopsy results and subsequent RP outcomes.
Results: Median values for prostate-specific antigen level of the TRUS-guided biopsy group and the MRI-guided biopsy group were 6.67 and 5.86 ng/mL (p=0.303), respectively. Median prostate volume of each group (34.1 mL vs. 23.5 mL, p=0.007), number of positive cores (2.0 vs. 3.0, p=0.001) and maximum cancer/core rate (30.0% vs. 60.0%, p<0.001) were statistically different. Positive core rates of each group were 21.9% and 87.1%, respectively. Pathologic T stage was the only variable that showed difference in surgical outcomes (p=0.002).
Most of PCa was confirmed as clinically significant PCa after RP in MRI-guided biopsy group (95%).
Conclusions: MRI-guided biopsy showed higher positive core rate and detection rate of clinically significant PCa than TRUS-guided biopsy in repeat biopsy setting. Prospective multicenter large-scale study and accumulation of data is expected to further define superiority of the MRI-guided biopsy. KCI Citation Count: 0 |
---|---|
ISSN: | 2951-603X 2982-7043 |
DOI: | 10.22465/kjuo.2017.15.2.72 |